Esperion Therapeutics
ESPR
#6584
Rank
A$1.18 B
Marketcap
A$4.60
Share price
0.63%
Change (1 day)
206.81%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.73. In 2024 the company made an earnings per share (EPS) of A-$0.33 an increase over its 2023 EPS that were of A-$3.08.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79135.31%
2024A-$0.33-89.15%
2023A-$3.08-40.28%
2022A-$5.15-62.87%
2021A-$13.8880.38%
2020A-$7.6950.14%
2019A-$5.12-53.18%
2018A-$10.957.41%
2017A-$10.19110.81%
2016A-$4.8347.35%
2015A-$3.280.89%
2014A-$3.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.90-362.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$61.75-8,606.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.87 1,122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.28-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.03-380.00%๐Ÿ‡บ๐Ÿ‡ธ USA